The North America Telecare Market would witness market growth of 4.3% CAGR during the forecast period (2021-2027).
Telemedicine, or telecare, is the virtual delivery of healthcare services over telecommunications infrastructures, such as tests and consultations. Numerous companies have already initiated or deployed telemedicine initiatives. Even small and independent medical practices are beginning to use telemedicine as an effort to cope with local retail clinics and avoid losing patients. Healthcare facilities can receive several benefits by leveraging telemedicine features. Moreover, it has the potential to increase efficiency and profitability, along with improving patient access to medical services. This factor would facilitate the penetration of telecare services
Telecare solutions are considered beneficial in improving health outcomes while also lowering costs. When compared to traditional approaches, telecare services save money for patients, providers, as well as market players. Telemedicine has lowered healthcare costs while boosting efficiency with better chronic illness management, shorter travel times, pooled healthcare professional staffing, and reduced hospital stays. As a result of all of these factors, the telecare market is anticipated to grow significantly over the forecast period.
Telecare is a rapidly developing aspect of healthcare across the United States, owing to the country's high adoption of innovative healthcare technologies and the rising burden of chronic diseases. Telecare has enhanced care management, improved patients' quality of life, as well as significantly reduced healthcare costs. Moreover, according to the data shared by the National Library of Medicines, Chronic wounds are estimated to affect 2% of the population in the United States. Chronic wounds cause a negative impact on people all around the world. According to a 2016 research from Wales, chronic wounds affect 6% of the population, costing the NHS 5.5 percent of its budget.
The US market dominated the North America Telecare Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $1,411.1 million by 2027. The Canada market is poised to grow at a CAGR of 6.6% during (2021 - 2027). Additionally, The Mexico market would exhibit a CAGR of 5.7% during (2021 - 2027).
Based on Product Type, the market is segmented into Activity Monitoring and Remote Medication Management. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Telecare Market is Estimated to reach $5.5 Billion by 2027, at a CAGR of 5.7%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Pfizer, Inc., Sanofi S.A., Johnson & Johnson, AllScripts Healthcare Solutions, Inc., AT&T, Inc., Samsung Electronics Co., Ltd., Apple, Inc., Qualcomm, Inc., and Google LLC.
Scope of the Study
Market Segments Covered in the Report:
By Product Type
- Activity Monitoring
- Remote Medication Management
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Abbott Laboratories
- Pfizer, Inc.
- Sanofi S.A.
- Johnson & Johnson
- AllScripts Healthcare Solutions, Inc.
- AT&T, Inc.
- Samsung Electronics Co., Ltd.
- Apple, Inc.
- Qualcomm, Inc.
- Google LLC
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Telecare Market, by Product Type
1.4.2 North America Telecare Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements: 2020, Mar – 2021, Dec) Leading Players
Chapter 4. North America Telecare Market by Product Type
4.1 North America Activity Monitoring Market by Country
4.2 North America Remote Medication Management Market by Country
Chapter 5. North America Telecare Market by Country
5.1 US Telecare Market
5.1.1 US Telecare Market by Product Type
5.2 Canada Telecare Market
5.2.1 Canada Telecare Market by Product Type
5.3 Mexico Telecare Market
5.3.1 Mexico Telecare Market by Product Type
5.4 Rest of North America Telecare Market
5.4.1 Rest of North America Telecare Market by Product Type
Chapter 6. Company Profiles
6.1 Abbott Laboratories
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Product Launches and Product Expansions:
6.2 Pfizer, Inc.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional Analysis
6.2.4 Research & Development Expense
6.3 Sanofi S.A.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Product Launches and Product Expansions:
6.4 Johnson and Johnson
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental &Regional Analysis
6.4.4 Research & Development Expenses
6.5 AllScripts Healthcare Solutions, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional & Segmental Analysis
6.5.4 Research & Development Expenses
6.5.5 Recent strategies and developments:
6.5.5.1 Acquisition and Mergers:
6.6 AT&T, Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.6.5 Recent strategies and developments:
6.6.5.1 Partnerships, Collaborations, and Agreements:
6.7 Samsung Electronics Co., Ltd. (Samsung Group)
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental and Regional Analysis
6.7.4 Research & Development Expense
6.7.5 Recent strategies and developments:
6.7.5.1 Partnerships, Collaborations, and Agreements:
6.7.5.2 Product Launches and Product Expansions:
6.7.6 SWOT Analysis
6.8 Apple, Inc.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Product and Regional Analysis
6.8.4 Research & Development Expense
6.8.5 Recent strategies and developments:
6.8.5.1 Partnerships, Collaborations, and Agreements:
6.8.6 SWOT Analysis
6.9 Qualcomm, Inc.
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental and Regional Analysis
6.9.4 Research & Development Expense
6.9.5 SWOT Analysis
6.10. Google LLC
6.10.1 Company Overview
6.10.2 Financial Analysis
6.10.3 Segmental and Regional Analysis
6.10.4 Research & Development Expense
6.10.5 Recent strategies and developments:
6.10.5.1 Partnerships, Collaborations, and Agreements:
6.10.6 SWOT Analysis
TABLE 1 North America Telecare Market, 2017 - 2020, USD Million
TABLE 2 North America Telecare Market, 2021 - 2027, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Telecare Market
TABLE 4 Product Launches And Product Expansions– Telecare Market
TABLE 5 Acquisition and Mergers– Telecare Market
TABLE 6 North America Telecare Market by Product Type, 2017 - 2020, USD Million
TABLE 7 North America Telecare Market by Product Type, 2021 - 2027, USD Million
TABLE 8 North America Activity Monitoring Market by Country, 2017 - 2020, USD Million
TABLE 9 North America Activity Monitoring Market by Country, 2021 - 2027, USD Million
TABLE 10 North America Remote Medication Management Market by Country, 2017 - 2020, USD Million
TABLE 11 North America Remote Medication Management Market by Country, 2021 - 2027, USD Million
TABLE 12 North America Telecare Market by Country, 2017 - 2020, USD Million
TABLE 13 North America Telecare Market by Country, 2021 - 2027, USD Million
TABLE 14 US Telecare Market, 2017 - 2020, USD Million
TABLE 15 US Telecare Market, 2021 - 2027, USD Million
TABLE 16 US Telecare Market by Product Type, 2017 - 2020, USD Million
TABLE 17 US Telecare Market by Product Type, 2021 - 2027, USD Million
TABLE 18 Canada Telecare Market, 2017 - 2020, USD Million
TABLE 19 Canada Telecare Market, 2021 - 2027, USD Million
TABLE 20 Canada Telecare Market by Product Type, 2017 - 2020, USD Million
TABLE 21 Canada Telecare Market by Product Type, 2021 - 2027, USD Million
TABLE 22 Mexico Telecare Market, 2017 - 2020, USD Million
TABLE 23 Mexico Telecare Market, 2021 - 2027, USD Million
TABLE 24 Mexico Telecare Market by Product Type, 2017 - 2020, USD Million
TABLE 25 Mexico Telecare Market by Product Type, 2021 - 2027, USD Million
TABLE 26 Rest of North America Telecare Market, 2017 - 2020, USD Million
TABLE 27 Rest of North America Telecare Market, 2021 - 2027, USD Million
TABLE 28 Rest of North America Telecare Market by Product Type, 2017 - 2020, USD Million
TABLE 29 Rest of North America Telecare Market by Product Type, 2021 - 2027, USD Million
TABLE 30 Key Information – Abbott Laboratories
TABLE 31 Key Information – Pfizer, Inc.
TABLE 32 Key Information – Sanofi S.A.
TABLE 33 Key information –Johnson and Johnson
TABLE 34 Key Information – AllScripts Healthcare Solutions, Inc.
TABLE 35 Key Information – AT&T, Inc.
TABLE 36 Key Information –Samsung Electronics Co., Ltd.
TABLE 37 Key Information – Apple, Inc.
TABLE 38 Key Information – Qualcomm, Inc.
TABLE 39 Key Information – Google LLC
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2017-2021)
FIG 4 Key Strategic Move: (Partnerships, Collaborations, and Agreements: 2020, Mar – 2021, Dec) Leading Players
FIG 5 Recent strategies and developments: Samsung Electronics Co., Ltd.
FIG 6 SWOT Analysis: Samsung Electronics CO. Ltd.
FIG 7 SWOT Analysis: apple, Inc.
FIG 8 SWOT Analysis: Qualcomm, Inc.
FIG 9 SWOT Analysis: Alphabet Inc. (Google LLC)